biostudies-literatureUnknown15Nicolas A<h4>Background</h4>Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc).<h4>Objective</h4>We performed an overview of the diagnostic approaches, follow-up and treatment strategies used in France for the management of SSc-associated ILD (SSc-ILD).<h4>Design structured nationwide online surveymethods</h4>A structured nationwide online survey was submitted to participants <i>via</i> the French Medical Societies for Internal Medicine and Pneumology, and research groups on SSc-ILD from May 2018 to June 2020. The 79 multiple-choice and 9 open-ended questions covered the screening of ILD at baseline, monitoring of patients with established SSc-ILD and its management. Fourteen optional vignettes exploring different clinical phenotypes of SSc-ILD were submitTherapeutic advances in musculoskeletal disease1759720X231159712https://www.ebi.ac.uk/biostudies/studies/S-EPMC10176589biostudies-literatureSystemic sclerosis associated interstitial lung disease: a survey of current practices in France.PMC10176589Queyrel VMouthon LMekinian AHachulla ELaunay DGroupe Orphalung, Groupe Francophone de Recherche sur la SclérodermieGachet BLeroy SUzunhan YMartis NNicolas ACottin VfalseSystemic sclerosis associated interstitial lung disease: a survey of current practices in France.<h4>Background</h4>Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc).<h4>Objective</h4>We performed an overview of the diagnostic approaches, follow-up and treatment strategies used in France for the management of SSc-associated ILD (SSc-ILD).<h4>Design structured nationwide online surveymethods</h4>A structured nationwide online survey was submitted to participants <i>via</i> the French Medical Societies for Internal Medicine and Pneumology, and research groups on SSc-ILD from May 2018 to June 2020. The 79 multiple-choice and 9 open-ended questions covered the screening of ILD at baseline, monitoring of patients with established SSc-ILD and its management. Fourteen optional vignettes exploring different clinical phenotypes of SSc-ILD were submit2023-01-01T00:00:00Z20232025-04-26T01:44:30.117Z2025-04-06T10:11:07.841ZS-EPMC101765893718785510.1177/1759720X231159712